Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD

Respiratory Medicine

Volumn 107, Issue 6, 2013, Pages 854-862

  Abrahams, Roger ^a   Moroni Zentgraf, Petra ^b   Ramsdell, Joe ^c   Schmidt, Hendrik ^b   Joseph, Elizabeth ^d   Karpel, Jill ^e  

^a Morgantown Pulmonary Clinical Research   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c UC San Diego Health Sciences   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e Rhinebeck Equine LLP   (United States)

Author keywords

BEA2180; Chronic obstructive pulmonary disease; Exacerbations; Respimat ; Tiotropium; Transition Dyspnoea Index

Indexed keywords

BEA 2180; CHOLINERGIC RECEPTOR BLOCKING AGENT; PLACEBO; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEADACHE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCORING SYSTEM; SINUSITIS; SMOKING; ST GEORGE'S RESPIRATORY QUESTIONNAIRE; TRANSITION DYSPNOEA INDEX; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

AGED; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TREATMENT OUTCOME;

EID: 84877578572     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.02.005     Document Type: Article

References (31)

1. P. Anderson Use of Respimat soft mist inhaler in COPD patients Int J Chron Obstruct Pulmon Dis 1 2006 251 259
2. R. Balkrishnan, and D.B. Christensen Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease Clin Ther 22 2000 452 469
3. E.D. Bateman, D. Tashkin, and N. Siafakas A one-year trial of tiotropium Respimat plus usual therapy in COPD patients Respir Med 104 2010 1460 1472
4. L.M. Cecere, C.G. Slatore, and J.E. Uman Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD) COPD 9 2012 251 258
5. M. Decramer, S. Rennard, and T. Troosters COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention COPD 5 2008 235 256
6. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, and J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852
7. J.F. Donohue Combination therapy for chronic obstructive pulmonary disease: clinical aspects Proc Am Thorac Soc 2 2005 272 281
8. GOLD Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2011 Global Strategy for The Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
9. N.J. Gross Tiotropium bromide Chest 126 2004 1946 1953
10. D. Halpin, S. Menjoge, and K. Viel Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations Prim Care Respir J 18 2009 106 113
11. R. Hodder, and D. Price Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler Int J Chron Obstruct Pulmon Dis 4 2009 381 390
12. R. Hodder, P.R. Reese, and T. Slaton Asthma patients prefer Respimat soft mist inhaler to turbuhaler Int J Chron Obstruct Pulmon Dis 4 2009 225 232
13. P.W. Jones, F.H. Quirk, C.M. Baveystock, and P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire Am Rev Respir Dis 145 1992 1321 1327
14. ® in patients with chronic obstructive pulmonary disease (COPD) 2012 Asian Pacific Society of Respirology [APSR] Congress [abstract]
15. D.A. Mahler, D.H. Weinberg, C.K. Wells, and A.R. Feinstein The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 1984 751 758
16. F. Maltais, A. Hamilton, and D. Marciniuk Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD Chest 128 2005 1168 1178
17. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338
18. MRC Medical research council guidelines for good clinical practice in clinical trials 1998 Medical Research Council Guidelines for Good Clinical Practice in Clinical Trials
19. S.P. Newman Inhaler treatment options in COPD Eur Respir Rev 14 2005 102 103
20. P.H. Quanjer, G.J. Tammeling, and J.E. Cotes Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society Eur Respir J Suppl 16 1993 5 40
21. W. Schurmann, S. Schmidtmann, P. Moroni, D. Massey, and M. Qidan Respimat soft mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction Treat Respir Med 4 2005 53 61
22. T.A. Seemungal, G.C. Donaldson, and E.A. Paul Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1418 1422
23. R.M. Shavelle, D.R. Paculdo, S.J. Kush, D.M. Mannino, and D.J. Strauss Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study Int J Chron Obstruct Pulmon Dis 4 2009 137 148
24. J.J. Soler-Cataluna, M.A. Martinez-Garcia, and S.P. Roman Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Thorax 60 2005 925 931
25. E. Stahl, A. Lindberg, and S.A. Jansson Health-related quality of life is related to COPD disease severity Health Qual Life Outcome. 3 2005 56
26. D.P. Tashkin Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? Curr Opin Pulm Med 11 2005 121 128
27. D.P. Tashkin, B. Celli, and S. Senn A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 2008 1543 1554
28. J.A. van Noord, P.J. Cornelissen, and J.L. Aumann The efficacy of tiotropium administered via Respimat soft mist inhaler or handihaler in COPD patients Respir Med 103 2009 22 29
29. C. Vogelmeier, B. Hederer, and T. Glaab Tiotropium versus salmeterol for the prevention of exacerbations of COPD N Engl J Med 364 2011 1093 1103
30. H. Watz, B. Waschki, T. Meyer, and H. Magnussen Physical activity in patients with COPD Eur Respir J 33 2009 262 272
31. WHO Burden of COPD. The World Health Organization 2012 Burden of COPD. The World Health Organization